This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuaillon, E.
Right arrow Articles by Ducos, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuaillon, E.
Right arrow Articles by Ducos, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2007, p. 3077-3081, Vol. 45, No. 9
0095-1137/07/$08.00+0     doi:10.1128/JCM.00111-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Impact of Hepatitis C Virus (HCV) Genotypes on Quantification of HCV RNA in Serum by COBAS AmpliPrep/COBAS TaqMan HCV Test, Abbott Antiretroviral Therapy HCV RealTime Assay, and VERSANT HCV RNA Assay{triangledown}

Edouard Tuaillon,1 Anne-Marie Mondain,1 Laure Ottomani,1 Laurent Roudière,1 Pascal Perney,2 Marie-Christine Picot,4 Fabienne Séguret,4 François Blanc,2 Dominique Larrey,3 Philippe Van de Perre,1 and Jacques Ducos1*

Unité Hépatites Virales, Laboratoire de Virologie, Hôpital Lapeyronie,1 Service de Médecine Interne E,2 Institut des Maladies de l'Appareil Digestif, Hôpital Saint-Eloi,3 Département de l'Informatique Médicale Hôpital Arnaud de Villeneuve, CHU de Montpellier, France4

Received 16 January 2007/ Returned for modification 3 May 2007/ Accepted 11 June 2007

The VERSANT HCV RNA 3.0 (bDNA), COBAS AmpliPrep/COBAS TaqMan HCV, and Abbott ART HCV RealTime assays were compared for hepatitis C virus RNA quantification in 158 clinical specimens (genotypes 1 to 5). RNA values differed significantly between methods (P < 0.0001), and mean titer differences ranged from 0.01 to 0.50 log10 IU/ml depending on the genotypes.

* Corresponding author. Mailing address: Unité Hépatites Virales, Laboratoire de Virologie, Hôpital Lapeyronie, av. du Doyen G. Giraud, 34295 Montpellier, France. Phone: 33 467 338 336. Fax: 33 467 338 334. E-mail: j-ducos{at}chu-montpellier.fr

{triangledown} Published ahead of print on 20 June 2007.

Journal of Clinical Microbiology, September 2007, p. 3077-3081, Vol. 45, No. 9
0095-1137/07/$08.00+0     doi:10.1128/JCM.00111-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vermehren, J., Kau, A., Gartner, B. C., Gobel, R., Zeuzem, S., Sarrazin, C. (2008). Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification. J. Clin. Microbiol. 46: 3880-3891 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»